At a glance · for buyers and watchdogs
HSL Pathology has won £353.0m across 9 public-sector buyers, with 8 live contracts. No active Companies House risk flags.
Why: top buyer Public Health England at 83% · 0 active risk flags · 0 modifications.
Decision signals
Active red flags0
Company statusActive
Live contracts8 of 14
Top-buyer concentration83%
Category exposure—
Contract modifications0
About this supplier
Supplier-written pitch — services, mission, and a hero image.
—
No supplier-written profile yet
When a supplier verifies ownership of this page they can publish a pitch, link their website, and request meetings. Until then we only show independently sourced data below.
Social value projects
Outcomes attributed by the supplier, each linked to its source contract.
No social-value projects published
Jobs, skills, environmental and inequality outcomes appear here once a claimed supplier attributes them to awarded contracts. We mark each as self-reported or buyer-confirmed.